Toshifumi Tada
Corporate Officer/Principal at MITSUBISHI CHEMICAL GROUP CORPORATION
Profile
Toshifumi Tada is currently the Director-Asia & Europe Business Division at Mitsubishi Chemical Group Corp.
Prior to this, he served as the President, Chief Executive Officer & Director at Medicago, Inc.
Toshifumi Tada active positions
Companies | Position | Start |
---|---|---|
MITSUBISHI CHEMICAL GROUP CORPORATION | Corporate Officer/Principal | 31/03/2024 |
Former positions of Toshifumi Tada
Companies | Position | End |
---|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Chief Executive Officer | 31/03/2024 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
Private companies | 1 |
---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Stock Market
- Insiders
- Toshifumi Tada